CONCERTA ER 36 MG TABLET

Methylphenidate hydrochloride
$13.0409per EA
High Outlier
DEA Schedule CII

Strength

36 mg/1

NDC

50458058601

Classification

Brand

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

New Drug (NDA)

FDA Application

NDA021121

On Market Since

8/1/2000

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-0.0%

3M

-0.1%

6M

-0.2%

1Y

-0.2%

3Y

-0.3%

5Y

+6.5%

All

+80.3%

Generic Alternatives

Save up to 95%

1 alternative • Same active ingredient